Health service security of patients with 8 certain rare diseases: evidence from China’s national system for health service utilization of patients with healthcare insurance

From Rare to Neglected Diseases: A Sustainable and Inclusive Healthcare Perspective for Reframing the Orphan Drugs Issue

(2019) Marialuisa Saviano et al.   Sustainability

Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016

(2018) Nancy Fullman et al.   LANCET

The challenge and promise of rare disease diagnosis in China

(2017) Xin Ni et al.   Science China-Life Sciences

Chinese health care system and clinical epidemiology

(2017) Yuelian Sun et al.   Clinical Epidemiology

Challenges of rare diseases in China

(2016) Dong Dong et al.   LANCET

The availability and affordability of orphan drugs for rare diseases in China

(2016) Shiwei Gong et al.   Orphanet Journal of Rare Diseases

Epidemiological research, scientific research, and applied research on rare diseases in China: current challenges and prospects for the future

(2016) Qi Tang et al.   Expert Opinion on Orphan Drugs

Focusing on rare diseases in China: are we there yet?

(2015) Li Yang et al.   Orphanet Journal of Rare Diseases

Documenting rare disease data in China

(2015) H. Lin et al.   SCIENCE

PHP3 RARE DISEASES, ORPHAN DRUGS, AND THE LEGISLATION IN CHINA

(2011) YJ Zhang et al.   VALUE IN HEALTH

Rare diseases and legislation in China

(2010) Jing-Bo Wang et al.   LANCET